Dolma Impact Fund, the first international private equity firm focused on Nepal, made a first close of its second fund earlier this year.

More Articles

Latest News and Updates

  • 14 Feb, 2025
  • 7 Min

Dr. Krishna Maharjan studies chromosomes and cell structures. One of Nepal’s leading cytogeneticists, he broadened my understanding of how artificial intelligence is transforming health care...